Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid

Clinical trial NCT05649579 · COMPLETED

Trial details

NCT number: NCT05649579
Sponsor: Peking University First Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Bullous Pemphigoid

Start date: 2022-09-01
Primary completion: 2022-12-31
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.